In a study of mostly pretreated patients with unresectable advanced pancreatic cancer, participants received a WT-1 peptide-pulsed DC vaccine with or without other peptides, including MUC-1, CEA, or CA-125. The gene discussed is WT1; the disease is familial pancreatic carcinoma.